Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma.
Muroyama R, Kato N, Yoshida H, Otsuka M, Moriyama M, Wang Y, Shao RX, Dharel N, Tanaka Y, Ohta M, Tateishi R, Shiina S, Tatsukawa M, Fukai K, Imazeki F, Yokosuka O, Shiratori Y, Omata M. Muroyama R, et al. Among authors: tateishi r. J Hepatol. 2006 Dec;45(6):805-12. doi: 10.1016/j.jhep.2006.07.025. Epub 2006 Sep 22. J Hepatol. 2006. PMID: 17050029
Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma.
Tanaka Y, Kanai F, Tada M, Tateishi R, Sanada M, Nannya Y, Ohta M, Asaoka Y, Seto M, Shiina S, Yoshida H, Kawabe T, Yokosuka O, Ogawa S, Omata M. Tanaka Y, et al. Among authors: tateishi r. J Hepatol. 2008 Nov;49(5):746-57. doi: 10.1016/j.jhep.2008.06.019. Epub 2008 Jul 9. J Hepatol. 2008. PMID: 18752864
Perihepatic lymph node enlargement is a negative predictor for sustained responses to pegylated interferon-α and ribavirin therapy for Japanese patients infected with hepatitis C virus genotype 1.
Hikita H, Enooku K, Satoh Y, Yoshida H, Nakagawa H, Masuzaki R, Tateishi R, Soroida Y, Sato M, Suzuki A, Gotoh H, Iwai T, Yokota H, Koike K, Yatomi Y, Ikeda H. Hikita H, et al. Among authors: tateishi r. Hepatol Res. 2013 Oct;43(10):1005-12. doi: 10.1111/hepr.12061. Epub 2013 Jan 29. Hepatol Res. 2013. PMID: 23356977
Tumor markers are more useful in patients undergoing surveillance for hepatocellular carcinoma with unreliable results by ultrasonography.
Mikami S, Tateishi R, Hagiwara S, Sato M, Minami T, Uchino K, Enooku K, Sato T, Nakagawa H, Masuzaki R, Asaoka Y, Kondo Y, Shiina S, Ikeda H, Omata M, Yoshida H, Koike K. Mikami S, et al. Among authors: tateishi r. Hepatol Res. 2015 Apr;45(4):415-22. doi: 10.1111/hepr.12365. Epub 2014 Jun 19. Hepatol Res. 2015. PMID: 24861870
393 results